| pubmed-article:18340527 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C0024204 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C1522495 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C0449820 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:18340527 | lifeskim:mentions | umls-concept:C1519941 | lld:lifeskim |
| pubmed-article:18340527 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18340527 | pubmed:dateCreated | 2009-1-20 | lld:pubmed |
| pubmed-article:18340527 | pubmed:abstractText | Axillary lymph node dissection (ALND) is the standard treatment for patients with sentinel node (SN) metastasis, but most of these patients have negative non-sentinel nodes (non-SN). We have developed a scoring system (the Tenon score) to help identify a subgroup of patients who have a low risk of having non-SN metastases and who may thus forgo ALND. Here we validated the Tenon score in an independent cohort of SN-positive patients. | lld:pubmed |
| pubmed-article:18340527 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18340527 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18340527 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18340527 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18340527 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18340527 | pubmed:issn | 1573-7217 | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:BogdanoffDD | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:GuilleminFran... | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:RouzierRomanR | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:UzanSergeS | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:FondrinierEri... | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:DaraiEmileE | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:SeinceNathali... | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:BarrangerEmma... | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:CoutantCharle... | lld:pubmed |
| pubmed-article:18340527 | pubmed:author | pubmed-author:RodriguesAnab... | lld:pubmed |
| pubmed-article:18340527 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18340527 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:18340527 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18340527 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18340527 | pubmed:pagination | 537-43 | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:meshHeading | pubmed-meshheading:18340527... | lld:pubmed |
| pubmed-article:18340527 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18340527 | pubmed:articleTitle | Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. | lld:pubmed |
| pubmed-article:18340527 | pubmed:affiliation | Department of Obstetrics and Gynecology, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Paris, France. charles.coutant@tnn.aphp.fr | lld:pubmed |
| pubmed-article:18340527 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18340527 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:18340527 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18340527 | pubmed:publicationType | Validation Studies | lld:pubmed |
